Osivax Company
Osivax is a clinical stage biotechnology company developing a pipeline of vaccines and immunotherapies.
.png)
Headquarters:
Lyon, Rhone-Alpes, France
Industry:
Atrificial Vectors and Immune Cells
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
5
Funding Status:
Early Stage Venture
Last Funding Type:
Grant
Founded Date:
2017-01-01
Total Funding:
46143932
Last Funding Date:
2020-07-08